CE vs PLX · rev $10.28B vs P/E 31, rev $53.4M
Celanese Corporation (CE) versus Protalix Biotherapeutics Inc (PLX) — a side-by-side from cached financials, not a winner call.
Celanese Corporation (CE) is a chemicals company listed on US.
Protalix Biotherapeutics Inc (PLX) is a biotechnology company listed on US.
Latest reported CE revenue for 2024-12-31 was $10.28B. Net income was -$1.51B. Revenue was down 6.0% from 2023-12-31 to 2024-12-31. CE currently screens at market cap $5.92B.
Latest reported PLX revenue for 2024-12-31 was $53.4M. Net income was $2.9M. Revenue was down 18.5% from 2023-12-31 to 2024-12-31. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
CE currently screens at market cap $5.92B. PLX currently screens at market cap $122.6M and trailing P/E 30.8.
Not investment advice. Open the CE and PLX stock pages for the full models.
Not investment advice.